眼科治療薬の世界市場 2023-2027

当レポートでは眼科治療薬の市場規模は、2022年から2027年の間に157億2000万米ドル、予測期間中のCAGRは6.25%で成長すると予測しています。

当レポートでは、眼科治療薬市場の全体分析、市場規模と予測、動向、成長促進要因・課題、約25のベンダーを網羅したベンダー分析などを提供しています。

現在の市場動向と促進要因、市場環境全体に関する最新の分析を提供しています。市場は、眼疾患の有病率の増加、新規治療薬の承認と強力な医薬品パイプライン、抗VEGF阻害剤の強力な取り込みによって牽引されています。

本調査では、今後数年間における眼科治療薬市場の成長を促進する主な理由の一つとして、新規ドラッグデリバリーシステムの開発を挙げています。また、戦略的提携の増加や遺伝子治療製品の研究の増加は、市場の大きな需要につながるでしょう。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 市場情勢

• 市場エコシステム

第3章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2022
• 市場の見通し：2022-2027年の予測

第4章 市場規模実績

• 世界の眼科治療薬市場2017～2021年
• 製品セグメント分析2017-2021
• タイプセグメント分析2017-2021
• 地域セグメント分析2017-2021
• 国セグメント分析2017-2021

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 製品別の市場セグメンテーション

• マーケット・セグメント
• 製品別比較
• 網膜障害治療 - 市場規模と予測 2022-2027
• 緑内障治療 - 市場規模と予測 2022-2027
• ドライアイ疾患治療薬 - 市場規模と予測 2022-2027
• 眼の感染症と炎症治療 - 市場規模と予測 2022-2027
• その他の治療薬 - 市場規模と予測 2022-2027
• 製品別の市場機会

第7章 タイプ別の市場セグメンテーション

• マーケット・セグメント
• タイプ別比較
• 処方薬 - 市場規模と予測 2022-2027
• 一般用医薬品 - 市場規模と予測 2022-2027
• タイプ別の市場機会

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米 - 市場規模と予測 2022-2027
• 欧州 - 市場規模と予測 2022-2027
• アジア - 市場規模と予測 2022-2027
• その他の地域（ROW） - 市場規模と予測 2022-2027
• 米国 - 市場規模と予測 2022-2027
• ドイツ - 市場規模と予測 2022-2027
• 英国 - 市場規模と予測 2022-2027
• フランス - 市場規模と予測 2022-2027
• 日本 - 市場規模と予測 2022-2027
• 地域情勢別の市場機会

第10章 促進要因、課題、および動向

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場動向

第11章 ベンダー情勢

• 概要
• ベンダー情勢
• 混乱の状況
• 業界のリスク

第12章 ベンダー分析

• 対象ベンダー
• ベンダーの市場ポジショニング
• AbbVie Inc.
• Aldeyra Therapeutics Inc.
• Bausch Health Co Inc.
• Bayer AG
• F. Hoffmann La Roche Ltd.
• Novartis AG
• Ocular Therapeutix Inc.
• Otsuka Pharmaceutical Co. Ltd.
• Oxurion NV
• Pfizer Inc.
• Regeneron Pharmaceuticals Inc.
• Santen Pharmaceutical Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Visufarma

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Product
• Exhibits6: Executive Summary - Chart on Market Segmentation by Type
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibits18: Historic Market Size - Data Table on Global ophthalmology therapeutics market 2017 - 2021 ($ billion)
• Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
• Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
• Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)
• Exhibits23: Five forces analysis - Comparison between 2022 and 2027
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
• Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
• Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
• Exhibits29: Chart on Market condition - Five forces 2022 and 2027
• Exhibits30: Chart on Product - Market share 2022-2027 (%)
• Exhibits31: Data Table on Product - Market share 2022-2027 (%)
• Exhibits32: Chart on Comparison by Product
• Exhibits33: Data Table on Comparison by Product
• Exhibits34: Chart on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits35: Data Table on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits36: Chart on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits37: Data Table on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits38: Chart on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits39: Data Table on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits40: Chart on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits41: Data Table on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits42: Chart on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits43: Data Table on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits44: Chart on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits45: Data Table on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits46: Chart on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits47: Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits48: Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits49: Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits50: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits51: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibits52: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits53: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibits54: Market opportunity by Product ($ billion)
• Exhibits55: Chart on Type - Market share 2022-2027 (%)
• Exhibits56: Data Table on Type - Market share 2022-2027 (%)
• Exhibits57: Chart on Comparison by Type
• Exhibits58: Data Table on Comparison by Type
• Exhibits59: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibits60: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibits61: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
• Exhibits62: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
• Exhibits63: Chart on OTC drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibits64: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibits65: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
• Exhibits66: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
• Exhibits67: Market opportunity by Type ($ billion)
• Exhibits68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits69: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• Exhibits71: Chart on Geographic comparison
• Exhibits72: Data Table on Geographic comparison
• Exhibits73: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits74: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibits75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibits76: Data Table on North America - Year-over-year growth 2022-2027 (%)
• Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• Exhibits81: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits82: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibits83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• Exhibits85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibits87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibits89: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits90: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibits91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibits92: Data Table on US - Year-over-year growth 2022-2027 (%)
• Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• Exhibits97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibits99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibits100: Data Table on UK - Year-over-year growth 2022-2027 (%)
• Exhibits101: Chart on France - Market size and forecast 2022-2027 ($ billion)
• Exhibits102: Data Table on France - Market size and forecast 2022-2027 ($ billion)
• Exhibits103: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibits104: Data Table on France - Year-over-year growth 2022-2027 (%)
• Exhibits105: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibits106: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibits107: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• Exhibits109: Market opportunity By Geographical Landscape ($ billion)
• Exhibits110: Impact of drivers and challenges in 2022 and 2027
• Exhibits111: Overview on Criticality of inputs and Factors of differentiation
• Exhibits112: Overview on factors of disruption
• Exhibits113: Impact of key risks on business
• Exhibits114: Vendors covered
• Exhibits115: Matrix on vendor position and classification
• Exhibits116: AbbVie Inc. - Overview
• Exhibits117: AbbVie Inc. - Product / Service
• Exhibits118: AbbVie Inc. - Key news
• Exhibits119: AbbVie Inc. - Key offerings
• Exhibits120: Aldeyra Therapeutics Inc. - Overview
• Exhibits121: Aldeyra Therapeutics Inc. - Product / Service
• Exhibits122: Aldeyra Therapeutics Inc. - Key offerings
• Exhibits123: Bausch Health Co Inc. - Overview
• Exhibits124: Bausch Health Co Inc. - Business segments
• Exhibits125: Bausch Health Co Inc. - Key news
• Exhibits126: Bausch Health Co Inc. - Key offerings
• Exhibits127: Bausch Health Co Inc. - Segment focus
• Exhibits128: Bayer AG - Overview
• Exhibits129: Bayer AG - Business segments
• Exhibits130: Bayer AG - Key news
• Exhibits131: Bayer AG - Key offerings
• Exhibits132: Bayer AG - Segment focus
• Exhibits133: F. Hoffmann La Roche Ltd. - Overview
• Exhibits134: F. Hoffmann La Roche Ltd. - Business segments
• Exhibits135: F. Hoffmann La Roche Ltd. - Key news
• Exhibits136: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibits137: F. Hoffmann La Roche Ltd. - Segment focus
• Exhibits138: Novartis AG - Overview
• Exhibits139: Novartis AG - Business segments
• Exhibits140: Novartis AG - Key offerings
• Exhibits141: Novartis AG - Segment focus
• Exhibits142: Ocular Therapeutix Inc. - Overview
• Exhibits143: Ocular Therapeutix Inc. - Product / Service
• Exhibits144: Ocular Therapeutix Inc. - Key offerings
• Exhibits145: Otsuka Pharmaceutical Co. Ltd. - Overview
• Exhibits146: Otsuka Pharmaceutical Co. Ltd. - Product / Service
• Exhibits147: Otsuka Pharmaceutical Co. Ltd. - Key offerings
• Exhibits148: Oxurion NV - Overview
• Exhibits149: Oxurion NV - Product / Service
• Exhibits150: Oxurion NV - Key offerings
• Exhibits151: Pfizer Inc. - Overview
• Exhibits152: Pfizer Inc. - Product / Service
• Exhibits153: Pfizer Inc. - Key news
• Exhibits154: Pfizer Inc. - Key offerings
• Exhibits155: Regeneron Pharmaceuticals Inc. - Overview
• Exhibits156: Regeneron Pharmaceuticals Inc. - Product / Service
• Exhibits157: Regeneron Pharmaceuticals Inc. - Key offerings
• Exhibits158: Santen Pharmaceutical Co. Ltd. - Overview
• Exhibits159: Santen Pharmaceutical Co. Ltd. - Product / Service
• Exhibits160: Santen Pharmaceutical Co. Ltd. - Key offerings
• Exhibits161: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibits162: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibits163: Sun Pharmaceutical Industries Ltd. - Key offerings
• Exhibits164: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits165: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits166: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits167: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits168: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits169: Visufarma - Overview
• Exhibits170: Visufarma - Product / Service
• Exhibits171: Visufarma - Key offerings
• Exhibits172: Inclusions checklist
• Exhibits173: Exclusions checklist
• Exhibits174: Currency conversion rates for US$
• Exhibits175: Research methodology
• Exhibits176: Validation techniques employed for market sizing
• Exhibits177: Information sources
• Exhibits178: List of abbreviations

Technavio has been monitoring the ophthalmology therapeutics market and is forecast to grow by $15.72 bn during 2022-2027, accelerating at a CAGR of 6.25% during the forecast period. Our report on the ophthalmology therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in the prevalence of eye diseases, approval of novel therapeutics and strong drug pipeline, and strong uptake of anti-VEGF inhibitors.

Technavio's ophthalmology therapeutics market is segmented as below:

By Product

• Retinal disorder
• Glaucoma
• Dry eye disease
• Eye infections and inflammation
• Other therapeutics

By Type

• Prescription drugs
• OTC drugs

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the development of novel drug delivery systems as one of the prime reasons driving the ophthalmology therapeutics market growth during the next few years. Also, increase in strategic alliances and increasing research on gene therapy products will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the ophthalmology therapeutics market covers the following areas:

• Ophthalmology therapeutics market sizing
• Ophthalmology therapeutics market forecast
• Ophthalmology therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading ophthalmology therapeutics market vendors that include AbbVie Inc., Adrif Vision, Aldeyra Therapeutics Inc., Bausch Health Co Inc., Bayer AG, Eyeris Vision Care Pvt. Ltd., F. Hoffmann La Roche Ltd., Grevis Pharmaceuticals Pvt. Ltd., Novartis AG, Ocular Therapeutix Inc., Otsuka Pharmaceutical Co. Ltd., Oxurion NV, Pfizer Inc., Regeneron Pharmaceuticals Inc., Santen Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Swissvision, Teva Pharmaceutical Industries Ltd., Vee Remedies, and Visufarma. Also, the ophthalmology therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2022
• 3.4 Market outlook: Forecast for 2022-2027
• Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

• 4.1 Global ophthalmology therapeutics market 2017 - 2021
• Exhibit 18: Historic Market Size - Data Table on Global ophthalmology therapeutics market 2017 - 2021 ($ billion)
• 4.2 Product Segment Analysis 2017 - 2021
• Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ billion)
• 4.3 Type Segment Analysis 2017 - 2021
• Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ billion)
• 4.4 Geography Segment Analysis 2017 - 2021
• Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ billion)
• 4.5 Country Segment Analysis 2017 - 2021
• Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2022-2027 (%)
• Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Retinal disorder therapeutics - Market size and forecast 2022-2027
• Exhibit 34: Chart on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 35: Data Table on Retinal disorder therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 36: Chart on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 37: Data Table on Retinal disorder therapeutics - Year-over-year growth 2022-2027 (%)
• 6.4 Glaucoma therapeutics - Market size and forecast 2022-2027
• Exhibit 38: Chart on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 39: Data Table on Glaucoma therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 40: Chart on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 41: Data Table on Glaucoma therapeutics - Year-over-year growth 2022-2027 (%)
• 6.5 Dry eye disease therapeutics - Market size and forecast 2022-2027
• Exhibit 42: Chart on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 43: Data Table on Dry eye disease therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 44: Chart on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 45: Data Table on Dry eye disease therapeutics - Year-over-year growth 2022-2027 (%)
• 6.6 Eye infections and inflammation therapeutics - Market size and forecast 2022-2027
• Exhibit 46: Chart on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 47: Data Table on Eye infections and inflammation therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 48: Chart on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 49: Data Table on Eye infections and inflammation therapeutics - Year-over-year growth 2022-2027 (%)
• 6.7 Other therapeutics - Market size and forecast 2022-2027
• Exhibit 50: Chart on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 51: Data Table on Other therapeutics - Market size and forecast 2022-2027 ($ billion)
• Exhibit 52: Chart on Other therapeutics - Year-over-year growth 2022-2027 (%)
• Exhibit 53: Data Table on Other therapeutics - Year-over-year growth 2022-2027 (%)
• 6.8 Market opportunity by Product
• Exhibit 54: Market opportunity by Product ($ billion)

7 Market Segmentation by Type

• 7.1 Market segments
• Exhibit 55: Chart on Type - Market share 2022-2027 (%)
• Exhibit 56: Data Table on Type - Market share 2022-2027 (%)
• 7.2 Comparison by Type
• Exhibit 57: Chart on Comparison by Type
• Exhibit 58: Data Table on Comparison by Type
• 7.3 Prescription drugs - Market size and forecast 2022-2027
• Exhibit 59: Chart on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibit 60: Data Table on Prescription drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibit 61: Chart on Prescription drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 62: Data Table on Prescription drugs - Year-over-year growth 2022-2027 (%)
• 7.4 OTC drugs - Market size and forecast 2022-2027
• Exhibit 63: Chart on OTC drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibit 64: Data Table on OTC drugs - Market size and forecast 2022-2027 ($ billion)
• Exhibit 65: Chart on OTC drugs - Year-over-year growth 2022-2027 (%)
• Exhibit 66: Data Table on OTC drugs - Year-over-year growth 2022-2027 (%)
• 7.5 Market opportunity by Type
• Exhibit 67: Market opportunity by Type ($ billion)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 69: Chart on Market share By Geographical Landscape 2022-2027 (%)
• Exhibit 70: Data Table on Market share By Geographical Landscape 2022-2027 (%)
• 9.2 Geographic comparison
• Exhibit 71: Chart on Geographic comparison
• Exhibit 72: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2022-2027
• Exhibit 73: Chart on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 74: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
• Exhibit 75: Chart on North America - Year-over-year growth 2022-2027 (%)
• Exhibit 76: Data Table on North America - Year-over-year growth 2022-2027 (%)
• 9.4 Europe - Market size and forecast 2022-2027
• Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
• Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
• Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
• 9.5 Asia - Market size and forecast 2022-2027
• Exhibit 81: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 82: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
• Exhibit 83: Chart on Asia - Year-over-year growth 2022-2027 (%)
• Exhibit 84: Data Table on Asia - Year-over-year growth 2022-2027 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
• Exhibit 85: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 86: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
• Exhibit 87: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• Exhibit 88: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
• 9.7 US - Market size and forecast 2022-2027
• Exhibit 89: Chart on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 90: Data Table on US - Market size and forecast 2022-2027 ($ billion)
• Exhibit 91: Chart on US - Year-over-year growth 2022-2027 (%)
• Exhibit 92: Data Table on US - Year-over-year growth 2022-2027 (%)
• 9.8 Germany - Market size and forecast 2022-2027
• Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
• Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
• Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
• 9.9 UK - Market size and forecast 2022-2027
• Exhibit 97: Chart on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 98: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
• Exhibit 99: Chart on UK - Year-over-year growth 2022-2027 (%)
• Exhibit 100: Data Table on UK - Year-over-year growth 2022-2027 (%)
• 9.10 France - Market size and forecast 2022-2027
• Exhibit 101: Chart on France - Market size and forecast 2022-2027 ($ billion)
• Exhibit 102: Data Table on France - Market size and forecast 2022-2027 ($ billion)
• Exhibit 103: Chart on France - Year-over-year growth 2022-2027 (%)
• Exhibit 104: Data Table on France - Year-over-year growth 2022-2027 (%)
• 9.11 Japan - Market size and forecast 2022-2027
• Exhibit 105: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 106: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
• Exhibit 107: Chart on Japan - Year-over-year growth 2022-2027 (%)
• Exhibit 108: Data Table on Japan - Year-over-year growth 2022-2027 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 109: Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 110: Impact of drivers and challenges in 2022 and 2027
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 111: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 112: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 113: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 114: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 115: Matrix on vendor position and classification
• 12.3 AbbVie Inc.
• Exhibit 116: AbbVie Inc. - Overview
• Exhibit 117: AbbVie Inc. - Product / Service
• Exhibit 118: AbbVie Inc. - Key news
• Exhibit 119: AbbVie Inc. - Key offerings
• 12.4 Aldeyra Therapeutics Inc.
• Exhibit 120: Aldeyra Therapeutics Inc. - Overview
• Exhibit 121: Aldeyra Therapeutics Inc. - Product / Service
• Exhibit 122: Aldeyra Therapeutics Inc. - Key offerings
• 12.5 Bausch Health Co Inc.
• Exhibit 123: Bausch Health Co Inc. - Overview
• Exhibit 124: Bausch Health Co Inc. - Business segments
• Exhibit 125: Bausch Health Co Inc. - Key news
• Exhibit 126: Bausch Health Co Inc. - Key offerings
• Exhibit 127: Bausch Health Co Inc. - Segment focus
• 12.6 Bayer AG
• Exhibit 128: Bayer AG - Overview
• Exhibit 129: Bayer AG - Business segments
• Exhibit 130: Bayer AG - Key news
• Exhibit 131: Bayer AG - Key offerings
• Exhibit 132: Bayer AG - Segment focus
• 12.7 F. Hoffmann La Roche Ltd.
• Exhibit 133: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 134: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 135: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 136: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 137: F. Hoffmann La Roche Ltd. - Segment focus
• 12.8 Novartis AG
• Exhibit 138: Novartis AG - Overview
• Exhibit 139: Novartis AG - Business segments
• Exhibit 140: Novartis AG - Key offerings
• Exhibit 141: Novartis AG - Segment focus
• 12.9 Ocular Therapeutix Inc.
• Exhibit 142: Ocular Therapeutix Inc. - Overview
• Exhibit 143: Ocular Therapeutix Inc. - Product / Service
• Exhibit 144: Ocular Therapeutix Inc. - Key offerings
• 12.10 Otsuka Pharmaceutical Co. Ltd.
• Exhibit 145: Otsuka Pharmaceutical Co. Ltd. - Overview
• Exhibit 146: Otsuka Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 147: Otsuka Pharmaceutical Co. Ltd. - Key offerings
• 12.11 Oxurion NV
• Exhibit 148: Oxurion NV - Overview
• Exhibit 149: Oxurion NV - Product / Service
• Exhibit 150: Oxurion NV - Key offerings
• 12.12 Pfizer Inc.
• Exhibit 151: Pfizer Inc. - Overview
• Exhibit 152: Pfizer Inc. - Product / Service
• Exhibit 153: Pfizer Inc. - Key news
• Exhibit 154: Pfizer Inc. - Key offerings
• 12.13 Regeneron Pharmaceuticals Inc.
• Exhibit 155: Regeneron Pharmaceuticals Inc. - Overview
• Exhibit 156: Regeneron Pharmaceuticals Inc. - Product / Service
• Exhibit 157: Regeneron Pharmaceuticals Inc. - Key offerings
• 12.14 Santen Pharmaceutical Co. Ltd.
• Exhibit 158: Santen Pharmaceutical Co. Ltd. - Overview
• Exhibit 159: Santen Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 160: Santen Pharmaceutical Co. Ltd. - Key offerings
• 12.15 Sun Pharmaceutical Industries Ltd.
• Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
• Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
• Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings
• 12.16 Teva Pharmaceutical Industries Ltd.
• Exhibit 164: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 165: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 166: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 167: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 168: Teva Pharmaceutical Industries Ltd. - Segment focus
• 12.17 Visufarma
• Exhibit 169: Visufarma - Overview
• Exhibit 170: Visufarma - Product / Service
• Exhibit 171: Visufarma - Key offerings

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 172: Inclusions checklist
• Exhibit 173: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 174: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 175: Research methodology
• Exhibit 176: Validation techniques employed for market sizing
• Exhibit 177: Information sources
• 13.5 List of abbreviations
• Exhibit 178: List of abbreviations